Počet záznamov: 1
imunoadhezíny CD4
SYS d016860 LBL 00000nx--j22000003--45-- 005 20240119201305.8 100 $a 19920712csloy0103----ba0 152 $b mesh 250 $a imunoadhezíny CD4 $x AD $x AE $x AN $x BI $x BL $x CF $x CH $x CL $x DE $x EC $x GE $x HI $x IM $x IP $x ME $x PD $x PH $x PO $x RE $x TO $x TU $x UL $x UR $8 slo 300 1-
$a 92; was CD4 IMMUNOADHESIN (NM) 1989-91 $8 eng 300 1-
$a Antigens, CD (1990-1991) $8 eng 300 1-
$a Antigens, Differentiation, T-Lymphocyte (1989) $8 eng 300 1-
$a IgG (1989-1991) $8 eng 330 1-
$a Chimeric molecules resulting from the fusion of recombinant soluble CD4 to the Fc portion of immunoglobulins. These have potential use in the therapy of AIDS since they possess both the gp120-binding and HIV-blocking properties of rCD4 as well as the long plasma half-life and Fc receptor-binding functions of immunoglobulin. $8 eng 450 $a CD4-IgG $5 e $8 eng 450 $a Immunoadhesins, CD4 $5 e $8 eng 450 $a CD4-IgG $5 e $8 slo 550 $3 sllk_un_auth*d007155 $Y Immunologic Factors $5 P $a faktory imunologické 686 $a D09.400.430.890.200.230 686 $a D12.644.541.500.697.249 686 $a D12.776.124.486.485.538.500.249 686 $a D12.776.124.486.485.680.697.249 686 $a D12.776.124.790.651.538.500.249 686 $a D12.776.124.790.651.680.660.249 686 $a D12.776.377.715.548.538.500.249 686 $a D12.776.377.715.548.680.660.249 686 $a D12.776.395.550.200.230 686 $a D12.776.543.550.200.230 686 $a D12.776.828.300.200 686 $a D23.050.301.350.230 750 $a CD4 Immunoadhesins $8 eng 801 -0
$a US $b DNLM $c 19920712 801 -2
$a SK $b BA006 $c 20000405 980 $x M
Počet záznamov: 1